Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen H. Gillespie

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Current Infectious Disease Reports|January 22, 2004
Cutaneous Larva MigransStephen H. Gillespie
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2016
The role of moxifloxacin in tuberculosis therapyStephen H Gillespie
Lancet (London, England)|January 26, 2002
Microbes sans frontièresStephen H Gillespie
Lancet (London, England)|March 6, 2004
New tricks from an old dog: streptococcal necrotising soft-tissue infectionsStephen H Gillespie
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
Studies of early bactericidal activity: new insights into isoniazid pharmacokineticsStephen H Gillespie
Antimicrobial Agents and Chemotherapy|January 18, 2002
Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspectiveStephen H Gillespie
Methods in Molecular Biology (Clifton, N.J.)|January 12, 2018
Using RT qPCR for Quantifying Mycobacteria marinum from In Vitro and In Vivo SamplesHan Xaio, Stephen H Gillespie
Current Opinion in Infectious Diseases|December 20, 2024
Tuberculosis molecular bacterial load assay in the management of tuberculosisStephen H Gillespie, Wilber Sabiiti
Frontiers in Antibiotics|January 16, 2025
Editorial: Preserving antibiotics: stewardship and effective treatment in low and middle income countriesAbdul Ghafur, Stephen H Gillespie
Recent Patents on Anti-Infective Drug Discovery|May 21, 2011
XDR-TB, what is it; how is it treated; and why is therapeutic failure so high?Stephen H Gillespie, Kasha Singh
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Current Infectious Disease Reports|January 22, 2004
Cutaneous Larva MigransStephen H. Gillespie
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2016
The role of moxifloxacin in tuberculosis therapyStephen H Gillespie
Lancet (London, England)|January 26, 2002
Microbes sans frontièresStephen H Gillespie
Lancet (London, England)|March 6, 2004
New tricks from an old dog: streptococcal necrotising soft-tissue infectionsStephen H Gillespie
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
Studies of early bactericidal activity: new insights into isoniazid pharmacokineticsStephen H Gillespie
Antimicrobial Agents and Chemotherapy|January 18, 2002
Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspectiveStephen H Gillespie
Methods in Molecular Biology (Clifton, N.J.)|January 12, 2018
Using RT qPCR for Quantifying Mycobacteria marinum from In Vitro and In Vivo SamplesHan Xaio, Stephen H Gillespie
Current Opinion in Infectious Diseases|December 20, 2024
Tuberculosis molecular bacterial load assay in the management of tuberculosisStephen H Gillespie, Wilber Sabiiti
Frontiers in Antibiotics|January 16, 2025
Editorial: Preserving antibiotics: stewardship and effective treatment in low and middle income countriesAbdul Ghafur, Stephen H Gillespie
Recent Patents on Anti-Infective Drug Discovery|May 21, 2011
XDR-TB, what is it; how is it treated; and why is therapeutic failure so high?Stephen H Gillespie, Kasha Singh
Pageof 16